Personalized Medicine Summit: March 19 Webcast March 11, 2009
Posted by Dr. Bertalan Meskó in Personalized medicine, Web 2.0, Webinar.2 comments
A free online webcast summit on “Personalized Medicine,” will be held on the 19th of March and hosted by BrightTALK™. It will include 6 presentations from leading personalized medicine experts on topics including:
- Michael Amos, National Institute for Standards and Technology Measurement – “Measurement Technology Challenges for Personalized Medicine”
- Peter Keeling, CEO, Diaceutics – “Designing Return on Investment into Personalized Medicine”
- Mondher Toumi, Chief Scientific Officer, Creativ-Ceutical – “The Impacts of Personalized Medicine: Pricing and Market Access”
- Brandon M. Welch, President & CEO, SGenomics – “The Need of Clinical Decision Support in Personalized Medicine”
You can review the agenda and register for the Personalized Medicine summit at here.
Metabolomics Webinar August 17, 2008
Posted by Dr. Bertalan Meskó in science, Web 2.0, Webinar.add a comment
There will be a promising webinar focusing on metabolomics organized by Genetic Engineering & Biotechnology News on the 28th of August. You can register here.
Metabolomics: Analytics, Tools, and Applications (August 28, 2008; 1:00 pm EDT; 19:00 CEST)
Metabolomics—the small molecule chemical footprint of biological processes—is poised to take its rightful place beside genomics and proteomics as an enabling biotechnique. Scientists involved in the discovery and clinical development of new drugs should attend this free webinar to learn how this technique can advance research.
Key learning points for this webinar:
- Examples of metabolomes and where they fit into the larger biological picture
- Analytical techniques for uncovering and exploiting metabolomics—capabilities and limitations
- Implications of metabolomics for biomedicine, drug discovery, and development
- Metabolomics case studies in diabetes and prostate cancer
Your hosts for this webinar, Chris Beecher, Ph.D. (University of Michigan), and Chris Newgard, Ph.D.DukeUniversity), Steven Fischer, Ph.D. (Agilent Technologies), bring years of combined experience surrounding metabolomics. They will present specific examples of how metabolomics can be applied to translational medicine, diabetes, and prostate cancer.
Science Webinar: CNVs vs SNPs July 12, 2008
Posted by Dr. Bertalan Meskó in science, Webinar.2 comments
Science Magazine will organize a webinar about copy number variations and single nucleotide polymorphisms.
CNVs vs SNPs: Understanding Human Structural Variation in Disease
July 16, 2008 at 12 noon Eastern Time (9 a.m. Pacific, 4 p.m. GMT)
Genetic variation—differences in both the coding and noncoding portions of our DNA—is what makes each human being a unique individual. It also can determine our unique susceptibility to disease. Exhaustive analysis of human single nucleotide polymorphisms (SNPs) has led to the identification of interesting SNP markers for certain disorders. But these small changes are not the whole picture. Copy number variations (CNVs)—gain or loss of segments of genomic DNA relative to a reference—have also been shown to be associated with several complex and common disorders. Using array-based comparative genomic hybridization (CGH) techniques, CNVs at multiple loci can be assessed simultaneously allowing for their identification and characterization. CNV microarrays allow exploration of the genome for sources of variability beyond SNPs that could explain the strong genetic component of several of these disorders. Now, advances in microarray probe density have provided more comprehensive coverage of CNVs, enabling more in depth genotyping research.
Speakers:
- Charles Lee, Ph.D., FACMG; Department of Pathology, Brigham and Women’s Hospital, Boston MA
- Lars Feuk, Ph.D., The Centre for Applied Genomics; The Hospital for Sick Children, Toronto, Ontario
- Alexandra I Blakemore, Ph.D., Division of Medicine, Imperial College London, United Kingdom
The moderator will be Sean Sanders, Ph.D., Commercial Editor, Science/AAAS.
Webcast: Genomic Medicine in Breast & Ovarian Cancer May 17, 2008
Posted by Dr. Bertalan Meskó in Cancer, Personalized medicine, Webinar.2 comments
My good friend, Steve Murphy, is going to come up with something interesting again. Helix Health, the first stand alone genomic medicine practice in the US, will host a free 90-minute webcast on the 21st of May, 2008 from 1:00-2:30 PM EDT on:
How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer
Click here to register.
Every hour, 150 people in the United States are diagnosed with cancer. Yet today, there are a growing number of people who are not waiting to hear that diagnosis. They are undergoing genetic testing to determine whether they have a genetic predisposition to the disease.
That’s exactly what Jessica Queller, author of Pretty Is What Changes, did after her mother, a breast cancer survivor, died of ovarian cancer. Jessica tested positive for the BRCA1 gene mutation and faced a most difficult decision. Jessica will join David Ewing Duncan, bestselling author of Masterminds: Genius, DNA
and the Quest to Rewrite Life, and a panel of distinguished medical and legal professionals to discuss how the doctor-patient relationship is changing and what the potential liability is for physicians in this new era of breast & ovarian cancer and genomic medicine.What should a doctor and patient do when a patient tests positive?
What is the risk in taking a “wait and see” approach?
Are there alternatives to radical surgery?
What are potential tort issues in predictive genetic testing and medical uses of
genetic tests?
